Dr. Hoos on Tools Available to Measure Ipilimumab's Success
Dr. Axel Hoos from Bristol Myers-Squibb on Tools Available to Measure Ipilimumab's Success
Axel Hoos, MD, PhD, the medical lead in Immunology/Oncology at Bristol-Myers Squibb describes the tools currently available and peer reviewed for the measurement of ipilimumab's success. These studies all need to be validated prospectively in comparison to standard processes.
Related Videos
Related Content
